Lithium Use in Patients with Dysarthria: Caution and Monitoring Required

Risks and Considerations

Patients with pre-existing dysarthria are at higher risk for worsening of their condition when taking lithium, according to the American Heart Association, as reported in Stroke 1
Pre-existing neurological conditions affecting speech, such as those seen in patients with stroke, increase the risk of lithium-induced dysarthria 1
Renal impairment increases lithium levels and risk of toxicity, as noted by the medical community, including Praxis Medical Insights 2

Baseline neurological assessment, including speech evaluation, is recommended before initiating lithium in patients with dysarthria, as suggested by Praxis Medical Insights 2
More frequent monitoring of lithium levels, at least twice weekly during initiation until stable, is advised for patients with dysarthria, according to the American Academy of Sleep Medicine 3
Regular clinical assessment for early signs of neurotoxicity, including worsening dysarthria, tremor, and ataxia, is necessary for patients on lithium, as recommended by Praxis Medical Insights 2

For patients with dysarthria who require lithium, speech therapy interventions, such as those tailored to the specific type of dysarthria, may help manage speech difficulties, as reported in Stroke 1
Computer-based speech therapy may be beneficial as a supplement to traditional speech therapy in patients with medication-induced dysarthria, according to Stroke 1
The American Academy of Sleep Medicine suggests considering alternative mood stabilizers, such as valproate, carbamazepine, or lamotrigine, in bipolar patients with dysarthria 3

Patients with stroke-related dysarthria require particularly careful monitoring if lithium is necessary, as noted in Stroke 1
Patients should be clearly informed about the risk of worsening speech disorders before starting lithium, as recommended by Praxis Medical Insights 2
Regular inositol supplementation monitoring is recommended if used concurrently with lithium, according to Praxis Medical Insights 4